BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 15583821)

  • 1. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide-Y family of peptides in the autocrine-paracrine regulation of adrenocortical function.
    Nussdorfer GG; Gottardo G
    Horm Metab Res; 1998; 30(6-7):368-73. PubMed ID: 9694565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an autocrine-paracrine role of adrenomedullin in the cultured rat adrenal zona glomerulosa cells.
    Andreis PG; Albertin G; Conconi MT; Carraro G; Malendowicz LK; Ziolkowska A; Nussdorfer GG
    Int J Mol Med; 2002 Oct; 10(4):401-5. PubMed ID: 12239585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
    Goumain M; Voisin T; Lorinet AM; Laburthe M
    Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to the reviews on neuropeptide Y.
    Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):135-40. PubMed ID: 15337366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NPY regulates catecholamine secretion from human adrenal chromaffin cells.
    Cavadas C; Silva AP; Mosimann F; Cotrim MD; Ribeiro CA; Brunner HR; Grouzmann E
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5956-63. PubMed ID: 11739470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S; Boey D; Herzog H
    Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evolution of NPY receptor subtypes.
    Larhammar D; Salaneck E
    Neuropeptides; 2004 Aug; 38(4):141-51. PubMed ID: 15337367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin and its receptors are expressed in the zona glomerulosa of human adrenal gland: evidence that ADM enhances proliferation and decreases apoptosis in cultured ZG cells.
    Rebuffat P; Forneris ML; Aragona F; Ziolkowska A; Malendowicz LK; Nussdorfer GG
    Int J Mol Med; 2002 Feb; 9(2):119-24. PubMed ID: 11786920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of neuropeptide Y on the rat adrenal cortex.
    Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
    Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
    DiMaggio DA; Farah JM; Westfall TC
    Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adrenomedullin and its fragment 22-52 on basal and ACTH-stimulated secretion of cultured rat adrenocortical cells.
    Ziolkowska A; Budzynska K; Trejter M; Tortorella C; Belloni AS; Malendowicz LK
    Int J Mol Med; 2003 May; 11(5):613-5. PubMed ID: 12684698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression cloning of a human brain neuropeptide Y Y2 receptor.
    Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
    Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the cloned atlantic cod neuropeptide Y-Yb receptor: peptide-binding requirements distinct from known mammalian Y receptors.
    Sharma P; Arvidsson AK; Wraith A; Beck-Sickinger AG; Jönsson-Rylander AC; Larhammar D
    Gen Comp Endocrinol; 1999 Sep; 115(3):422-8. PubMed ID: 10480994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.